Check out our most popular compounded medications! Get Started
Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients. It is primarily used to treat various types of headaches including migraines, cluster headaches, menstrual migraines, post-traumatic headaches, and tension-type headaches.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This formulation of Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency.
The topical gel is applied directly to the affected area, providing fast-acting relief from the symptoms of these conditions. The gel is easy to apply and is well-tolerated by most patients. The active ingredient in this formulation, Dihydroergotamine Mesylate, is a vasoconstrictor that helps to reduce inflammation and pain associated with these conditions. It also helps to reduce the frequency and severity of headaches.
It is easy to apply and is well-tolerated by most patients. If you have any questions about this formulation, please reach out to us at Bayview Pharmacy.
Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel is a semisolid formulation designed for the treatment of various types of headaches including migraines, cluster headaches, menstrual migraines, post-traumatic headaches, and tension-type headaches. This medication is dispensed through a pump mechanism, which allows for easy and precise application on the skin, targeting the treatment area directly.
The active ingredient, Dihydroergotamine Mesylate, is a vasoconstrictor that functions by narrowing the blood vessels in the brain. This action helps to alleviate the pain associated with these headache conditions. Additionally, it is believed to reduce inflammation and decrease the release of certain chemicals in the brain that can trigger headaches.
Application of Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel should be as per the directions provided by your healthcare provider. It is crucial to adhere to these instructions and not exceed the recommended dosage. Common side effects associated with this medication include nausea, vomiting, dizziness, and drowsiness. If any of these side effects are experienced, it is recommended to contact your healthcare provider immediately.
It is also essential to inform your healthcare provider about any other medications you are currently taking, as there may be potential interactions with Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel. If you have any queries or concerns regarding the use of this medication, do not hesitate to seek professional advice.
Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel is a specially compounded prescription medication designed to provide targeted treatment for various types of headaches, including migraines, cluster headaches, menstrual migraines, post-traumatic headaches, and tension-type headaches. This medication functions by constricting the blood vessels around the brain, reducing inflammation, and inhibiting the release of certain natural substances that trigger pain, nausea, and other migraine symptoms.
The gel is dispensed through a pump mechanism, which allows for easy and precise application directly onto the skin of the forehead and temples. Once applied, the medication is absorbed through the skin and enters the bloodstream, where it works to alleviate the symptoms of migraines. The gel should be applied twice daily, once in the morning and once in the evening, at the same time each day to ensure the medication's effectiveness.
It is crucial to adhere to the recommended dosage of the gel, as exceeding the prescribed amount may increase the risk of side effects. If any side effects are experienced, patients should immediately contact their healthcare provider. For any queries or concerns regarding the use of Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel, patients are encouraged to reach out for further assistance.
This is a semisolid formulation of Dihydroergotamine Mesylate, an active ingredient used for targeted treatment. It is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin. It ensures that the right amount of gel is dispensed each time, reducing the risk of over or under-dosing.
The gel has a semisolid, gel-like consistency. This makes it easy to apply and allows for targeted treatment or absorption of the active ingredients.
Apply the gel to the affected area as directed by your healthcare provider. The pump mechanism will dispense the right amount of gel for application.
It's important to use this medication as directed by your healthcare provider. Some areas of the body may not be suitable for application. Always follow your healthcare provider's instructions.
If you accidentally apply too much gel, wipe off the excess with a clean tissue and wash the area with warm water. Contact your healthcare provider if you experience any adverse reactions.
If you have sensitive skin, it's important to discuss this with your healthcare provider before using this medication. They can provide guidance based on your specific skin condition and medical history.
If you miss a dose, apply it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
Before using other skin products, discuss it with your healthcare provider. Some products may interfere with the absorption or effectiveness of Dihydroergotamine Mesylate 2 mg/0.5 ml Topical Gel.
Store this medication at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
